Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Dermatology OTC Switches Loom Next For Consumer Health Growth

Oct 03 2016

• By Eileen Francis

Related Content

Merck Silence On OTC <em>Singulair</em> Speaks Volumes On Switch Outlook

Dec 11 2015

<em>Rhinocort</em> Switch Makes Three In OTC Intranasal Corticosteroid Market

Mar 26 2015

'Migraine Experience' Debuts <em>Excedrin</em> Advertising By Glaxo/Novartis JV

Apr 18 2016

J&J Invests In Consumer Business For Long Haul, Not Quick Sale

Sep 16 2016

CAGR For OTC Switch Forecast At 5%, But Without Statins, Asthma Treatments

Sep 14 2015

Bayer Shoulders Marketing Spend To Lift Consumer Product Sales

Jul 27 2016

Differin Gel Enters Changed Marketplace Since Last OTC Acne Drug Approval

Aug 22 2016

Sanofi 'Fine-Tuning' Cialis OTC Switch Application

Aug 01 2016

Related Companies

Sanofi

GSK plc

Johnson & Johnson

AstraZeneca PLC

Bayer AG

GSK plc

Johnson & Johnson

Perrigo Company PLC

Pfizer Inc.

Procter & Gamble

Prestige Consumer Healthcare Inc.

Merck & Co., Inc.

Additional Topics

United States Prescription To OTC Switch Dietary Supplements OTC Drugs Dermatology Consumer

More from Rx-to-OTC Switch

More from Health

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window